Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001209191-23-040641

Options or other derivatives

  • Director acquired 933,317 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Behbahani Ali Director 2023-07-03 Grant or award · Option to purchase Ordinary Shares +933,317 933,317 D
Loading xslF345X04/doc4.xml…